Literature DB >> 11230878

Nicotinic treatment of Alzheimer's disease.

P A Newhouse1, A Potter, M Kelton, J Corwin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230878     DOI: 10.1016/s0006-3223(00)01069-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  28 in total

1.  Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study.

Authors:  Julie A Dumas; Brenna C McDonald; Andrew J Saykin; Thomas W McAllister; Mary L Hynes; John D West; Paul A Newhouse
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

2.  Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects.

Authors:  Bianca Voss; Renate Thienel; Martina Reske; Thilo Kellermann; Abigail J Sheldrick; Sarah Halfter; Katrin Radenbach; Nadim J Shah; Ute Habel; Tilo T J Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-10-18       Impact factor: 5.270

3.  Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers.

Authors:  G Dunbar; P H Boeijinga; A Demazières; C Cisterni; R Kuchibhatla; K Wesnes; R Luthringer
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 4.  Phasic acetylcholine release and the volume transmission hypothesis: time to move on.

Authors:  Martin Sarter; Vinay Parikh; W Matthew Howe
Journal:  Nat Rev Neurosci       Date:  2009-05       Impact factor: 34.870

5.  Therapeutic Applications of Nicotinic Stimulation: Successes, Failures, and Future Prospects.

Authors:  Paul A Newhouse
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

6.  Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.

Authors:  Jason A Gandelman; Hakmook Kang; Ashleigh Antal; Kimberly Albert; Brian D Boyd; Alexander C Conley; Paul Newhouse; Warren D Taylor
Journal:  J Clin Psychiatry       Date:  2018-08-28       Impact factor: 4.384

Review 7.  Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia.

Authors:  Jason R Tregellas; Korey P Wylie
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

Review 8.  Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.

Authors:  Silvia Lima Costa; Victor Diogenes Amaral Silva; Cleide Dos Santos Souza; Cleonice Creusa Santos; Irmgard Paris; Patricia Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2016-03-07       Impact factor: 3.911

Review 9.  Nicotine and inflammatory neurological disorders.

Authors:  Wen-Hua Piao; Denise Campagnolo; Carlos Dayao; Ronald J Lukas; Jie Wu; Fu-Dong Shi
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

Review 10.  nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms.

Authors:  Martin Sarter; Vinay Parikh; William M Howe
Journal:  Biochem Pharmacol       Date:  2009-05-04       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.